氨基二硫代甲酸酯类化合物生物活性研究进展

doi:10.11944/j.issn.1000-0518.2015.02.140187

摘要/Abstract

摘要：

氨基二硫代甲酸酯类化合物由于其独特的分子结构,使其具有明显的抗肿瘤、抗菌、抗氧化以及杀虫等多种生物活性,已经成为近年来药物化学领域研究的重点。本文评述了近年来文献报道的氨基二硫代甲酸酯类化合物以及它们的主要生物活性,并对其今后的发展方向、应用前景做出展望。

关键词: 氨基二硫代甲酸酯, 生物活性

Abstract:

Dithiocarbamate compounds have become the focus of pharmaceutical chemistry in recent years due to their unique molecular structure with a variety of biological properties, such as anti-tumor, antibacterium, antioxidation and insecticidal activity. This article reviews recent progresses in the biological activities of dithiocarbamate compounds and gives prospects for their development and application.

Key words: dithiocarbamates, bioactivities

中图分类号:

O626

王晓娟, 李高伟, 孟团结, 刘澜涛, 赵文献. 氨基二硫代甲酸酯类化合物生物活性研究进展[J]. 应用化学, 2015, 32(2): 123-133.

WANG Xiaojuan ,LI Gaowei,MENG Tuanjie,LIU Lantao,ZHAO Wenxian . Research Progress in the Bioactivities of the Dithiocarbamates[J]. Chinese Journal of Applied Chemistry, 2015, 32(2): 123-133.

参考文献

[1] Lai C S,Vassilev V P,Wang T M. Method for in Vivo Reduction of Nitric Oxide Levels and Compositions Useful Therefor:US Pat.5847004[P],1998.
[2] Hidaka S,Funakoshi T,Shimada H, et al . Comparative Effects of Diethyldithiocarbamate and n -Benzyl- D -Glucamine Dithiocarbamate on cis -Diamminedichloroplatinum-Induced Toxicity in Kidney and Gastrointestinal Tract in Rats[J]. J Appl Toxicol ,1995,15(4):267-273.
[3] Tandon S K,Singh S,Jain V K, et al . Chelation in Metal Intoxication XXXⅧ:Effect of Structurally Different Chelating Agents in Treatment of Nickel Intoxication in Rat [J]. Fundam Appl Toxicol ,1996,31(2):141-148.
[4] Imamura H,Ohtake N,Jona,H, et al . Structure-activity Relationships of trans -3,5-Disubstituted Pyrrolidinylthio-1 β -methylcarbapenems.Part 1:J-111,347 and Related Compounds[J]. Bioorg Med Chem Lett ,2000,10(2):109-113.
[5] Len C,Boulognemerlo A S,Posted D J. Synthesis and Antifungal Activity of Novel Bis(dithiocarbamate) Derivatives of Glycerol[J]. J Agric Food Chem ,1996,44(9):2856-2858.
[6] Menezes D C,Vieira F T,de Lima G M, et al . Tin(Ⅳ) Complexes of Pyrrolidinedithiocarbamate:Synthesis, Characterisation and Antifungal Activity[J]. Eur J Med Chem ,2005,40(12):1277-1282.
[7] Schreck R,Meier B,Mannel D N, et al . Dithiocarbamates as Potent Inhibitors of Nuclear Factor Kappa B Activation in Intact Cells[J]. J Exp Med ,1992,175:1181-1194.
[8] Ha T,Li Y,Gao X, et al . Attenuation of Cardiac Hypertrophy by Inhibiting both mTOR and NFκB Activation in vivo [J]. Free Radic Biol Med ,2005,39(12):1570-1580.
[9] Mehta G R,Liu J,Constantinou A, et al . Cancer Chemopreventive Activity of Brassinin, a Phytoalexin from Cabbage[J]. Carcinogenesis ,1995,16(2):399-404.
[10] Robert M M,Rajesh N,Jerome K, et al . Cancer Chemopreventive Activity of Sulforamate Derivatives[J]. Eur J Med Chem ,2006,41(1):121-124.
[11] Pedras M S,Loukaci A,Okanga F I. The Cruciferous Phytoalexins Brassinin and Cyclobrassinin are Intermediates in the Biosynthesis of Brassilexin[J]. Bioorg Med Chem Lett ,1998,8(21):3037-3038.
[12] Gaspari P,Banerjee T,Malachowski W P, et al . Structure-Activity Study of Brassinin Derivatives as Indoleamine 2,3-Dioxygenase Inhibitors[J]. J Med Chem ,2006,49(2):684-692.
[13] Péter C,István Z,Borbála R, et al . Isobrassinin and Its Analogues:Novel Types of Antiproliferative Agents[J]. Bioorg Med Chem Lett ,2006,16(24):6273-6276.
[14] Zhang Y,Kensler T W,Cho C G, et al . Anticarcinogenic Activities of Sulforaphane and Structurally Related Synthetic Norbornyl Isothiocyanates[J]. Proc Natl Acad Sci USA ,1994,91(8):3147-3150.
[15] Gerhäuser C,You M,Liu J F, et al . Cancer Chemopreventive Potential of Sulforamate, a Novel Analogue of Sulforaphane That Induces Phase 2 Drug-metabolizing Enzymes[J]. Cancer Res ,1997,57(2):272-278.
[16] WEI Jun,CHENG Tieming,LI Runtao. Improved Synthesis of Sulforamate, a Cancer-chemopreventive Compound[J]. Chinese J Med Chem ,2002,47(12):159-160(in Chinese). 卫军,程铁明,李润涛. 化学防癌化合物sulforamate的合成改进[J]. 中国药物化学杂志,2002,47(12):159-160.
[17] Kosmeder II J W,Hirschelman W H,Song L S, et al . Cancer Chemopreventive Activity of Oxomate:A Monfunctional Inducer of Phase Ⅱ Detoxification Enzymes[C]. 224th ACS National Meeting: Division of Medicinal Chemistry,2002:98.
[18] Hirschelman W H,Kosmeder II J W,Song L S, et al . Design and Lead Optimization of Oxomate:A Novel Phase II Enzyme Inducer[C]. 224th ACS National Meeting:Division of Medicinal Chemistry,2002:178.
[19] Hirschelman W H,Li Y M,van Breemen R B, et al . Synthesis of Oxomate Metabolites: Potential Chemopreventive Agents[C]. 225th ACS National Meeting:Division of Medicinal Chemistry,2003:86.
[20] Chen D,Dou Q P. New Uses for Old Copper-binding Drugs:Converting the Pro-angiogenic Copper to a Specific Cancer Cell Death Inducer[J]. Expert Opin Ther Targets ,2008,12(6):739-748.
[21] Chen D,Cui Q C,Yang H J, et al . Disulfiram, a Clinically Used Anti-Alcoholism Drug and Copper-Binding Agent, Induces Apoptotic Cell Death in Breast Cancer Cultures and Xenografts via Inhibition of the Proteasome Activity[J]. Cancer Res ,2006,66(21):10425-10433.
[22] Pang H,Chen D,Cui Q C, et al . Sodium Diethyldithiocarbamate, an Aids Progression Inhibitor and a Copper-Binding Compound, Has Proteasome-Inhibitory and Apoptosis-Inducing Activities in Cancer Cells[J]. Int J Mol Med ,2007,19(5):809-816.
[23] Ziegler-Heitbrock H W,Sternsdorf T,Liese J, et al . Pyrrolidine Dithiocarbamate Inhibits Nf-Kappa B Mobilization and Tnf Production in Human Monocytes[J]. J Immunol ,1993,151(12):6986-6993.
[24] Cen D,Brayton D,Shahandeh B, et al . Disulfiram Facilitates Intracellular Cu Uptake and Induces Apoptosis in Human Melanoma Cells[J]. J Med Chem ,2004,47(27):6914-6920.
[25] Verhaegen S,McGowan A J,Brophy A R, et al . Inhibition of Apoptosis by Antioxidants in the Human Hl-60 Leukemia Cell Line[J]. Biochem Pharmacol ,1995,50(7):1021-1029.
[26] Cao S L,Feng Y P,Jiang Y Y, et al . Synthesis and in Vitro Antitumor Activity of 4(3 H )-Quinazolinone Derivatives with Dithiocarbamate Side Chains[J]. Bioorg Med Chem Lett ,2005,15(7):1915-1917.
[27] Cao S L,Feng Y P,Zheng X L, et al . Synthesis of Substituted-benzylamino- and Heterocyclylmethylamino-carbodithioate Derivatives of 4(3 H )-Quinazolinone and Their Cytotoxic Activity[J]. Arch Pharm ,2006,339(5):250-254.
[28] Cao S L,Wang Y,Zhu L, et al . Synthesis and Cytotoxic Activity of N -((2-Methyl-4(3 H )-quinazolinon-6-yl) methyl) dithiocarbamates[J]. Eur J Med Chem ,2010,45(9):3850-3857.
[29] Cao S L,Han Y,Yuan C Z, et al . Synthesis and Antiproliferative Activity of 4-Substituted- Piperazine-1-Carbodithioate Derivatives of 2,4-Diaminoquinazoline[J]. Eur J Med Chem ,2013,64:401-409.
[30] Guo B B,Ge Z M,Cheng T M, et al . Synthesis and Anti-Tumor Activities of 1,4-Bis [3-(Amino-Dithiocarboxy) Propionyl] Piperazine Derivatives[J]. Acta Pharmaceutica Sinica ,2001,36(3):185-187.
[31] Li R T,Cheng T M,Cui J R. Study on the Synthesis and Anticancer Activity of Dithiocarbamate:US Pat.1328999[P],2002.
[32] JIANG Xiaomei,LING Xiaomei,LI Runtao, et al . Analysis of Hydrochloride 4-Methyl-piperazine-1-carbodithioc Acid 3-Cyano-3,3-diphenyl-propyl Ester and Its Metabolites in Rats by HPLC-ESI/ITMSn[J]. Acta Pharmaceut Sin ,2006,41(11):1084-1089(in Chinese). 姜小梅,凌笑梅,李润涛,等. HPLC-ESI/ITMS n 法分析大鼠体内4-甲基哌嗪-1-二硫代甲酸-(3-氰基-3,3-二苯基)丙酯盐酸盐及其主要代谢物[J]. 药学学报,2006,41(11):1084-1089.
[33] Zhang N,Guo W,Wang L, et al . Effect of TM208 on QGY-7703 Xenograft Tumor Growth[J]. Anticancer Drugs ,2008,19(6):593-598.
[34] Hou X L,Ge Z M,Wang T M, et al . Dithiocarbamic Acid Esters as Anticancer Agent.Part 1:4-Substituted-Piperazine-1-Carbodithioic Acid 3-Cyano-3,3-Diphenyl-Propyl Esters[J]. Bioorg Med Chem Lett ,2006,16(16):4214-4219.
[35] Ning M R,Li Liang,Li J. In Vitro Screening of Reversible and Time-Dependent Inhibition on Cyp3a by Tm208 and Tm209 in Rat Liver Microsomes[J]. Acta Pharmaceut Sin B ,2012,2(2):181-187.
[36] Kong D T,Ling,X M,Han F B, et al . Identification of the Metabolite and Cytochrome P450 Isoforms Involved in Rat Liver Microsomal Metabolism of TM208[J]. J Chin Pharm Sci ,2008,17:30-34.
[37] Zahrana M A H,Salemb T A R,Samaka R M, et al . Design, Synthesis and Antitumor Evaluation of Novel Thalidomide Dithiocarbamate and Dithioate Analogs against Ehrlich Ascites Carcinoma-Induced Solid Tumor in Swiss Albino Mice[J]. Bioorg Med Chem ,2008,16(22):9708-9718.
[38] Qian Y,Ma G Y,Yang Y, et al . Synthesis, Molecular Modeling and Biological Evaluation of Dithiocarbamates as Novel Antitubulin Agents[J]. Bioorg Med Chem ,2010,18(12):4310-4316.
[39] Huang W,Ding Y,Miao Y, et al . Synthesis and Antitumor Activity of Novel Dithiocarbamate Substituted Chromones[J]. Eur J Med Chem ,2009,44(9):3687-3696.
[40] Bacharaju K,Jambula S R,Sivan S, et al . Design, Synthesis, Molecular Docking and Biological Evaluation of New Dithiocarbamates Substituted Benzimidazole and Chalcones as Possible Chemotherapeutic Agents[J]. Bioorg Med Chem Lett ,2012,22(9):3274-3277.
[41] Wang X J,Xu H W,Guo L L, et al . Synthesis and in Vitro Antitumor Activity of New Butenolide-Containing Dithiocarbamates[J]. Bioorg Med Chem Lett ,2011,21(10):3074-3077.
[42] Wang X J,Xu H W,Guo L L, et al . Synthesis of Various Substituted Spiro- and Bicyclethiazolidine-2-Thiones by a Multicomponent Reaction and Biological Evaluation in Vitro [J]. Heterocycles ,2011,83(5):1005-1012.
[43] Duan Y,Ma Y,Zhang E, et al . Design and Synthesis of Novel 1,2,3-Triazole-Dithiocarbamate Hybrids as Potential Anticancer Agents[J]. Eur J Med Chem ,2013,62:11-19.
[44] Duan Y,ZhengY,Li X, et al . Design, Synthesis and Antiproliferative Activity Studies of Novel 1,2,3-Triazole Dithiocarbamate-Urea Hybrids[J]. Eur J Med Chem ,2013,64:99-110.
[45] Zheng Y C,Duan Y C,Ma J L, et al . Triazole-Dithiocarbamate Based Selective Lysine Specific Demethylase 1(Lsd1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration[J]. J Med Chem ,2013,56(21):8543-8560.
[46] Ye X W,Zheng Y C,Duan Y C, et al . Synthesis and Biological Evaluation of Coumarin-1,2,3-Triazole Dithiocarbamate Hybrids as Potent Lsd1 Inhibitors[J]. Med Chem Comm ,2014,5(5):650-654.
[47] Ohtake N,Imamura H,Kiyonaga H, et al . Novel Dithiocarbamate Carbapenems1 with Anti-MRSA Activity[J]. Bioorg Med Chem Lett ,1997,7(13):1617-1622.
[48] Ren J L,Zhang E,Ye X W, et al . Design, Synthesis and Antibacterial Evaluation of Novel AHL Analogues[J]. Bioorg Med Chem Lett ,2013,23(14):4154-4156.
[49] Zou Y,Yu S,Li R, et al . Synthesis, Antifungal Activities and Molecular Docking Studies of Novel 2-(2,4-Difluorophenyl)-2-Hydroxy-3-(1 H -1,2,4-triazol-1-yl) Propyl Dithiocarbamates[J]. Eur J Med Chem ,2014,74:366-374.
[50] Horita Y,Takii T,Chiba T, et al . Synthesis of New Sugar Derivatives and Evaluation of Their Antibacterial Activities Against Mycobacterium Tuberculosis[J]. Bioorg Med Chem Lett ,2009,19(22):6313-6316.
[51] Güzel O,Salman A. Synthesis, Antimycobacterial and Antitumor Activities of New (1,1-Dioxido-3-Oxo-1,2-Benzisothiazol-2(3 H )-Yl)Methyl N , N -Disubstituted Dithiocarbamate/ O -Alkyldithiocarbonate Derivatives[J]. Bioorg Med Chem ,2006,14(23):7804-7815.
[52] Giglio J,Fern ndez S,Rey A, et al . Synthesis and Biological Characterisation of Novel Dithiocarbamate Containing 5-Nitroimidazole 99mTc-Complexes as Potential Agents for Targeting Hypoxia[J]. Bioorg Med Chem Lett ,2011,21(1):394-397.